Study published on new drug class targeting ACVR1 mutation for DIPG

By | 2019-05-16T15:20:11+00:00 May 9th, 2019|

Study published on new drug class targeting ACVR1 mutation for DIPG Scientists at The Institute of Cancer Research, London, along with colleagues at the Structural Genomics Consortium in Oxford, have published their findings on a new drug class that can kill brain cancer cells with mutations in the ACVR1 gene and shrink tumours in mice. Mutated versions [...]

Recording of M4K Pharma’s Scientific Update Meeting – April 24th, 2019

By | 2019-05-16T15:09:52+00:00 April 29th, 2019|

Listen to a recording of the April 24th 2019 Scientific Update Meeting Listen to our scientists and collaborators discuss the latest progress in M4K Pharma’s quest for a medicine for DIPG- a deadly children’s brain cancer. Everyone is invited to dial-in and join our live meetings. To find out when our next [...]

Recording of M4K Pharma’s Scientific Update Meeting – March 6th, 2019

By | 2019-03-20T21:47:26+00:00 March 15th, 2019|

Recording of M4K Pharma’s Scientific Update Meeting – March 6th, 2019 Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. Everyone is invited to dial-in and join our live meetings. To find out when our next meeting will be, follow [...]

Recording of M4K Pharma’s Scientific Update Meeting – December 4th, 2018.

By | 2018-12-07T21:20:51+00:00 December 7th, 2018|

Recording of M4K Pharma's Scientific Update Meeting - December 4th, 2018 Listen to our scientists and collaborators discuss the latest progress in M4K Pharma's quest for a medicine for DIPG- a deadly children's brain cancer. In this meeting, the team provides a comprehensive summary of the project accomplishments at the one year [...]

Can an open drug discovery model find a solution for rare brain cancers in children?

By | 2018-08-03T11:45:44+00:00 August 1st, 2018|

Can an open drug discovery model find a solution for rare brain cancers in children? Dr. Aled Edwards OICR-funded drug discovery project’s unique ‘open science’ business model is accelerating the search for a solution to lethal pediatric brain cancers. Diffuse intrinsic pontine glioma (DIPG) is a lethal and inoperable brain cancer with a median survival [...]